GLYCTK Antibody
-
中文名稱：GLYCTK兔多克隆抗體
-
貨號：CSB-PA219793
-
規格：￥2024
-
圖片：
-
Western blot analysis of extracts from 3T3 cells, using GLCTK antibody. -
Immunohistochemistry analysis of paraffin-embedded human brain tissue using GLCTK antibody. -
Immunofluorescence analysis of A549 cells, using GLCTK antibody.
-
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) GLYCTK Polyclonal antibody
-
Uniprot No.：
-
基因名：GLYCTK
-
宿主：Rabbit
-
反應種屬：Human,Mouse,Rat
-
免疫原：Synthesized peptide derived from internal of Human GLCTK.
-
免疫原種屬：Homo sapiens (Human)
-
克隆類型：Polyclonal
-
純化方式：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
濃度：It differs from different batches. Please contact us to confirm it.
-
產品提供形式：Liquid
-
應用范圍：ELISA,WB,IHC,IF
-
推薦稀釋比：
Application Recommended Dilution WB 1:500-1:3000 IHC 1:50-1:100 IF 1:100-1:500 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
基因功能參考文獻：
- Mutations in the GLYCTK gene is the cause of D-glycerate kinase deficiency and D-glyceric aciduria. PMID: 20949620
- Identification of two variants of the human glycerate kinase gene-Glycerate kinase 1 (GLYCTK1), longer variant, and Glycerate kinase 2 (GLYCTK2), shorter variant. PMID: 16753811
-
相關疾病：D-glyceric aciduria (D-GA)
-
亞細胞定位：[Isoform 1]: Cytoplasm.; [Isoform 2]: Cytoplasm. Mitochondrion.
-
蛋白家族：Glycerate kinase type-2 family
-
組織特異性：Widely expressed.
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
